Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute
Up next
Author


Hims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking a partnership with the Danish drug giant.

You May Also Like
Tesla sales plunge in France, showing Elon Musk may have a long way to go to restore the brand

Tesla sales plunge in France, showing Elon Musk may have a long way to go to restore the brand

Tesla’s sales have been under pressure in Europe, even after the rollout…

Amazon predicts cloud growth will gain steam as earnings bounce back

Amazon’s bumper holiday season and forecasts for accelerating cloud growth boosted its…
Has bitcoin halving lost its mojo? The crypto sees its worst ever post-halving performance. 

Has bitcoin halving lost its mojo? The crypto sees its worst ever post-halving performance. 

It’s been a year since bitcoin’s last halving. Investors expected the crypto’s…
Oaktree Capital calls commercial real estate ‘most acute area of risk’ right now

Oaktree Capital calls commercial real estate ‘most acute area of risk’ right now

Distressed-debt giant Oaktree Capital sees big opportunities in credit unfolding over the…